000 | 01128nam a2200349#i 4500 | ||
---|---|---|---|
001 | 0000013800 | ||
003 | NIH | ||
005 | 20240220144531.0 | ||
008 | 240220s2004 xx 000 0 eng d | ||
020 | _a158829076X | ||
020 | _a9781588290762 | ||
040 |
_aIMR _erda |
||
041 | _aeng | ||
060 | _aQZ267 | ||
090 |
_aQZ267 _bcan 2004 |
||
245 | 0 |
_aCancer chemoprevention: _bvolume 1 : promising cancer chemopreventive agents/ _cedited by Gary J. Kelloff, Ernest T. Hawk, Caroline C. Sigman |
|
264 | 1 |
_aNew Jersey: _bHumana Press, _c2004 |
|
300 |
_axvi, 697 pages: _billustration; _c29cm |
||
336 |
_atext _2rdacontent |
||
337 |
_aunmediated _2rdamedia |
||
338 |
_avolume _2rdacarrier |
||
490 | _aCancer drug discovery and development | ||
504 | _aIncludes bibliographical references and index | ||
650 | 1 | 0 |
_aAnticarcinogenic Agents _xtherapeutic use |
650 | 2 | 0 |
_aChemoprevention _xmethods |
650 | 2 | 0 |
_aNeoplasma _xprevention & control |
700 | _aHawk, Ernest T. | ||
700 | _aKelloff, Gary J. | ||
700 | _aSigman, Caroline | ||
830 | _aCancer drug discovery and development | ||
999 | _c21997 |